| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.15 | $69.02 (0%) | 🛒 Add to cart |
| 90 | $1.06 | $103.53 $95.03 (8%) | 🛒 Add to cart |
| 120 | $0.96 | $138.04 $115.03 (17%) | 🛒 Add to cart |
| 180 | $0.87 | $207.06 $157.05 (24%) | 🛒 Add to cart |
| 270 | $0.83 | $310.59 $223.07 (28%) | 🛒 Add to cart |
| 360 | $0.78
Best per pill | $414.12 $280.08 (32%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.53 | $46.01 (0%) | 🛒 Add to cart |
| 60 | $1.35 | $92.03 $81.02 (12%) | 🛒 Add to cart |
| 90 | $1.27 | $138.04 $114.03 (17%) | 🛒 Add to cart |
| 120 | $1.18 | $184.05 $142.04 (23%) | 🛒 Add to cart |
| 180 | $1.10 | $276.08 $198.06 (28%) | 🛒 Add to cart |
| 270 | $1.06 | $414.12 $285.08 (31%) | 🛒 Add to cart |
| 360 | $1.02
Best per pill | $552.16 $367.11 (34%) | 🛒 Add to cart |
| Product dosage: 700mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.60 | $48.01 (0%) | 🛒 Add to cart |
| 60 | $1.55 | $96.03 $93.03 (3%) | 🛒 Add to cart |
| 90 | $1.48 | $144.04 $133.04 (8%) | 🛒 Add to cart |
| 120 | $1.40 | $192.06 $168.05 (12%) | 🛒 Add to cart |
| 180 | $1.33 | $288.09 $240.07 (17%) | 🛒 Add to cart |
| 270 | $1.27 | $432.13 $344.10 (20%) | 🛒 Add to cart |
| 360 | $1.24
Best per pill | $576.17 $445.13 (23%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
levoflox
Product Description: Levoflox represents the third-generation fluoroquinolone antibiotic class, specifically formulated as levofloxacin hemihydrate. Available in 250mg, 500mg, and 750mg oral tablets alongside intravenous solutions, this broad-spectrum agent targets Gram-positive, Gram-negative, and atypical pathogens through DNA gyrase inhibition. What’s fascinating clinically isn’t just the spectrum coverage but how the S-(-) enantiomer configuration reduces neurologic side effects compared to older quinolones - something we only appreciated after analyzing adverse event reports from the first six months of post-market surveillance.
ciplox
Ciprofloxacin, commonly encountered in clinical practice as Ciplox, represents a cornerstone fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Its development marked a significant advancement in antimicrobial therapy, particularly for complex infections where older agents failed. We initially saw its potential in hospital-acquired pneumonias and complicated UTIs, but its utility has expanded significantly over the decades. The challenge, as with any potent agent, has always been balancing its remarkable efficacy with a mindful approach to its safety profile, something our team has debated extensively during formulary reviews.
cipro
Ciprofloxacin, commonly referred to by its brand name Cipro, represents a cornerstone in modern antimicrobial therapy. This fluoroquinolone antibiotic has been a workhorse in clinical practice for decades, particularly valued for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. What makes Cipro truly distinctive isn’t just its antibacterial potency but its unique pharmacokinetic profile that allows for excellent tissue penetration - something we’ve repeatedly observed makes the difference between adequate and exceptional clinical outcomes, especially in difficult-to-treat infections like those involving bone or the prostate.
floxin
Ofoxacin, commonly known by its brand name Floxin, represents a significant advancement in the fluoroquinolone class of antibiotics. This synthetic broad-spectrum antimicrobial agent has been a workhorse in clinical practice since its introduction, particularly valued for its potent activity against both Gram-positive and Gram-negative bacteria, including some atypical pathogens. Its development marked a shift towards agents with improved pharmacokinetics and a wider therapeutic window compared to earlier quinolones. In modern therapeutic regimens, Floxin occupies a crucial role, especially in managing respiratory, urinary tract, and sexually transmitted infections where other first-line agents may fail due to resistance or patient intolerance.
Levaquin: Potent Antibiotic for Resistant Bacterial Infections - Evidence-Based Review
Levofloxacin, commonly known by its brand name Levaquin, is a synthetic broad-spectrum fluoroquinolone antibiotic. It’s prescribed for treating various bacterial infections by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication. This agent has been a workhorse in hospitals and outpatient settings for decades, particularly for respiratory, urinary tract, and skin infections where other antibiotics fail. Its potency and bioavailability made it a go-to, but its profile carries significant warnings that every prescriber needs to weigh carefully.
Levoquin: Potent Antibacterial Therapy for Resistant Infections - Evidence-Based Review
Levoquin, known generically as levofloxacin, is a broad-spectrum fluoroquinolone antibiotic available in both oral and intravenous formulations. It’s a synthetic chemotherapeutic agent derived from nalidixic acid, specifically the L-isomer of ofloxacin, which gives it approximately twice the potency of the racemic mixture. In clinical practice, we reach for it when dealing with resistant or complicated infections where narrower-spectrum options have failed or are contraindicated. The molecule’s unique stereochemistry contributes to its enhanced antibacterial activity and favorable pharmacokinetic profile compared to earlier quinolones.
noroxin
Norfloxacin, a second-generation fluoroquinolone antibiotic, represents a critical tool in the antimicrobial arsenal for treating specific bacterial infections. Its development marked a significant advancement in targeting gram-negative pathogens with improved potency and a broader spectrum compared to earlier quinolones. In clinical practice, it’s primarily utilized for managing uncomplicated urinary tract infections (UTIs) and certain gastrointestinal infections caused by susceptible organisms. The drug’s mechanism, targeting bacterial DNA gyrase and topoisomerase IV, creates a bactericidal effect that effectively halts bacterial replication.
Omnicef: Effective Bacterial Infection Treatment Across Multiple Indications - Evidence-Based Review
Cefdinir, marketed under the brand name Omnicef, represents a significant advancement in oral cephalosporin antibiotics, specifically designed to overcome limitations of earlier generation agents while maintaining broad-spectrum coverage. As a third-generation cephalosporin, it bridges the gap between hospital and community practice with its reliable activity against common respiratory and skin pathogens. What really sets cefdinir apart isn’t just its chemical structure - it’s the practical clinical advantages we’ve observed over two decades of use: once-daily dosing stability, minimal gastrointestinal disruption compared to earlier agents, and that rare combination of pediatric formulation acceptability with adult dosing convenience.
a ret gel
Product Description: A Ret Gel represents a significant advancement in topical retinoid therapy, combining pharmaceutical-grade tretinoin with a sophisticated hydrogel delivery system. This medical device/drug combination product addresses one of the biggest challenges in dermatological treatment: delivering effective concentrations of retinoids while minimizing the irritation that often limits patient adherence. The hydrogel matrix creates a controlled-release environment that maintains tretinoin stability and enhances skin penetration compared to traditional cream or gel formulations.